Independent study results indicate that mean wear associated with Amedica’s MC2® silicon nitride femoral heads was ~15% lower than a BIOLOX®delta sample after five million cycles.
Tissue Regenix plans a 2018 launch for dCELL® decellularization technology in the U.S. for orthopaedic applications, initially addressing ACL repair.Â
Vexim completed enrollment in its FDA clinical trial comparing SpineJack® to balloon kyphoplasty on 152 patients with osteoporotic vertebral compression fractures.
GS Medical USA is launching AnyPlus® ACIF and the AnyPlus® Dual-Lead Pedicle Screw system in March 2017, to be followed by the AnyPlus® DLIF implant in 2Q17.
Nanovis completed alpha launch of FortiCore® PLIF, featuring a deeply-porous titanium scaffold with a PEEK core, and announced implantation of the 2,000th FortiCore implant.